CYTOSORBENTS CORPORATION (CTSO) Total assets 2016–2025
CYTOSORBENTS CORPORATION (CTSO) total assets at each fiscal year-end, per SEC filings.
$44.2MFY2025 · since FY2016: $9.7M → $44.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44.2M | -6.7% |
| FY2024 | $47.4M | -10.5% |
| FY2023 | $53.0M | -16.3% |
| FY2022 | $63.2M | -29.4% |
| FY2021 | $89.5M | -0.5% |
| FY2020 | $90.0M | +228.5% |
| FY2019 | $27.4M | -19.9% |
| FY2018 | $34.2M | +41.9% |
| FY2017 | $24.1M | +148.6% |
| FY2016 | $9.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTSO financial trends
CTSO RevenueCTSO Net incomeCTSO Net marginCTSO Gross profitCTSO Gross marginCTSO Operating incomeCTSO Operating marginCTSO Operating cash flowCTSO Free cash flowCTSO Capital expendituresCTSO Return on equityCTSO Stock buybacksCTSO Dividends paidCTSO Total liabilitiesCTSO Shareholders’ equityCTSO overview →